Mylan defeats Allergan's with U.S. Patent Trial and Appeal Board decision
Mylan announced the U.S. Court of Appeals for the Federal Circuit affirmed the decision of the U.S. Patent Trial and Appeal Board (PTAB), which found that tribal sovereign immunity cannot apply to prevent inter partesreview proceedings. July 20, 2018